Beijing Sun-Novo Pharmaceutical Research (688621.SH) has repurchased a total of 2.43% of its shares, spending 99.7484 million yuan.

Beijing Sun-Novo Pharmaceutical Research (688621.SH) announced that as of February 28, 2025, the company has repurchased a total of 2.716789 million shares through centralized bidding trading, accounting for 2.43% of the company's current total share capital. The highest price paid was 45.60 yuan per share and the lowest price paid was 34.05 yuan per share. The total amount paid was 99.7484 million yuan (excluding stamp duty, transaction fees, etc.).